摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(prop-2-yn-1-yl)pent-4-yn-1-amine | 1207669-92-8

分子结构分类

中文名称
——
中文别名
——
英文名称
2-(prop-2-yn-1-yl)pent-4-yn-1-amine
英文别名
2-(prop-2-ynyl)pent-4-yn-1-amine;2-prop-2-ynylpent-4-yn-1-amine
2-(prop-2-yn-1-yl)pent-4-yn-1-amine化学式
CAS
1207669-92-8
化学式
C8H11N
mdl
MFCD19215731
分子量
121.182
InChiKey
MKJKHEYGIGOTRI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.7
  • 重原子数:
    9
  • 可旋转键数:
    3
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    26
  • 氢给体数:
    1
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    2-(prop-2-yn-1-yl)pent-4-yn-1-amine 在 silver(1,10-phenanthroline)OTf 作用下, 以 乙腈 为溶剂, 反应 0.08h, 以85%的产率得到5-methyl-3-(prop-2-yn-1-yl)-3,4-dihydro-2H-pyrrole
    参考文献:
    名称:
    Mild and Efficient Desymmetrization of Diynes via Hydroamination: Application to the Synthesis of (±)-Monomorine I
    摘要:
    An efficient silver-catalyzed desymmetrization of amino diynes via hydroamination is reported. A variety of functionalized I-pyrroline derivatives were synthesized in 73% to 88% isolated yields (>98% by H-1 NMR in some cases). The usefulness of this mild hydroamination method was further shown by the desymmetrization of unprotected tert-hydroxy diynes. Structures of two transition states have been studied computationally. An application of this method was demonstrated by a short and efficient synthesis of (+/-)-monomorine I.
    DOI:
    10.1021/jo902674j
  • 作为产物:
    描述:
    2,2,2-trifluoro-N-(2-(prop-2-ynyl)pent-4-ynyl)acetamidepotassium carbonate 作用下, 以 甲醇 为溶剂, 反应 1.0h, 以94%的产率得到2-(prop-2-yn-1-yl)pent-4-yn-1-amine
    参考文献:
    名称:
    Mild and Efficient Desymmetrization of Diynes via Hydroamination: Application to the Synthesis of (±)-Monomorine I
    摘要:
    An efficient silver-catalyzed desymmetrization of amino diynes via hydroamination is reported. A variety of functionalized I-pyrroline derivatives were synthesized in 73% to 88% isolated yields (>98% by H-1 NMR in some cases). The usefulness of this mild hydroamination method was further shown by the desymmetrization of unprotected tert-hydroxy diynes. Structures of two transition states have been studied computationally. An application of this method was demonstrated by a short and efficient synthesis of (+/-)-monomorine I.
    DOI:
    10.1021/jo902674j
点击查看最新优质反应信息

文献信息

  • [EN] POLYMER CONJUGATE FOR DELIVERY OF A BIOACTIVE AGENT<br/>[FR] CONJUGUÉ POLYMÈRE POUR LA DÉLIVRANCE D'UN AGENT BIOACTIF
    申请人:POLYACTIVA PTY LTD
    公开号:WO2014134689A1
    公开(公告)日:2014-09-12
    The present invention relates in general to polymer-bioactive agent conjugates for delivering a bioactive agent to a subject. The polymer-bioactive agent conjugates contain triazole moieties in the polymer backbone and a bioactive moiety selected from prostaglandin analogues, β-blockers and mixtures thereof. The present invention also relates to methods for preparing the polymer conjugates using click chemical reactions, to monomer-bioactive agent conjugates suitable for preparing the polymer conjugates, and to pharmaceutical products comprising the polymer conjugates for the treatment of glaucoma.
    本发明一般涉及用于向受试者传递生物活性剂的聚合物-生物活性剂共轭物。聚合物-生物活性剂共轭物在聚合物骨架中含有三唑基团和从前列腺素类似物、β-受体阻滞剂和二者的混合物中选择的生物活性基团。本发明还涉及使用点击化学反应制备聚合物共轭物的方法,适用于制备聚合物共轭物的单体-生物活性剂共轭物,以及包含用于治疗青光眼的聚合物共轭物的药物产品。
  • POLYMER CONJUGATE FOR DELIVERY OF A BIOACTIVE AGENT
    申请人:POLYACTIVA PTY LTD
    公开号:US20160000929A1
    公开(公告)日:2016-01-07
    The presentinvention relates in general to polymer-bioactive agent conjugates for delivering a bioactive agent to a subject. The polymer-bioactive agent conjugates contain triazole moieties in the polymer backbone and a bioactive moiety selected from prostaglandin analogues, β-blockers and mixtures thereof. The present invention also relates to methods for preparing the polymer conjugates using click chemical reactions, to monomer-bioactive agent conjugates suitable for preparing the polymer conjugates, and to pharmaceutical products comprising the polymer conjugates for the treatment of glaucoma.
    本发明通常涉及聚合物-生物活性剂共轭物,用于将生物活性剂传递给对象。聚合物-生物活性剂共轭物在聚合物骨架中含有三唑基团和从前列腺素类似物、β受体阻滞剂和其混合物中选择的生物活性基团。本发明还涉及使用点击化学反应制备聚合物共轭物的方法,适用于制备聚合物共轭物的单体-生物活性剂共轭物,以及包含聚合物共轭物的制药产品,用于治疗青光眼。
  • Polymer conjugate for delivery of a bioactive agent
    申请人:POLYACTIVA PTY LTD
    公开号:US10113033B2
    公开(公告)日:2018-10-30
    The present invention relates in general to polymer-bioactive agent conjugates for delivering a bioactive agent to a subject. The polymer-bioactive agent conjugates contain triazole moieties in the polymer backbone and a bioactive moiety comprising prostaglandin analogues. The present invention also relates to methods for preparing the polymer conjugates using click chemical reactions, to monomer-bioactive agent conjugates suitable for preparing the polymer conjugates, and to pharmaceutical products comprising the polymer conjugates for the treatment of glaucoma.
    本发明总体上涉及用于向受试者输送生物活性剂的聚合物-生物活性剂共轭物。聚合物-生物活性剂共轭物的聚合物骨架中含有三唑分子,生物活性分子包括前列腺素类似物。本发明还涉及利用点击化学反应制备聚合物共轭物的方法、适用于制备聚合物共轭物的单体-生物活性剂共轭物,以及包含用于治疗青光眼的聚合物共轭物的药物产品。
  • US4511702A
    申请人:——
    公开号:US4511702A
    公开(公告)日:1985-04-16
  • US4567298A
    申请人:——
    公开号:US4567298A
    公开(公告)日:1986-01-28
查看更多

同类化合物

锡烷,三丁基(5,5-二甲基-1,3-己二炔基)- 甲基D1乙炔 溴化氢-乙炔络合物 氯(己-5-炔基)甲基硅烷 戊-4-炔-1-胺盐酸盐 庚-1,2,4-三烯-6-炔 四(3,3,3-三氟丙-1-炔基)锡烷 乙炔基甲基硅烷 乙炔基三氟硅烷 乙炔基(二甲基)硅烷 乙炔化汞 [1-13C]-叔丁基乙炔 S-2-丙炔-1-基甲烷硫代磺酸酯 7-溴-5-甲基庚-5-烯-1-炔 5-己炔胺盐酸盐 4-乙炔基环己烷甲醛 2-氰基乙炔基(环己基)汞 2-(丙-2-炔-1-基)戊-4-炔-1-醇 1-锂-3-甲基-1,2-丁二烯 1-癸炔-1,2-13C2 1-氯-3-乙炔基-2-甲基辛-2-烯 1-乙炔基环丙胺盐酸盐 1-乙炔-1-甲基-环己烷 1,7,13,19-二十四炔 1,1-二氯-2-乙炔基环丁烷 (己-5-炔基)二甲基硅烷 (S)-3-丁炔-2-胺 (R)-1-甲基-2-丙炔胺 (4-环丙基-3,4-二甲基己-1,5-二炔-3-基)环丙烷 (4-乙炔基环己基)甲醇 (1-乙炔基环丙基)甲醇 ((1-氯环丙基)乙炔基)锂 ethyl 4-[4-(tri-n-butylstannyl)-2-methyl-2-buten-1-yloxy]-2-butynoate (E)-1-bromo-6-methyl-2-octen-4-yne (Z)-1-bromo-6-methyl-2-octen-4-yne chloro-2 ureidoxy-1 butane 1,11-dimethyl-3,6,9,13,16,19,22,25,28-nonaoxa-bicyclo[9.9.9]nonacosane cis-3,7-dicyano-1-(methylene)bicyclo<4.3.0>nonane 2,2,3,3,4,4,5,5,6,6,7,7,8,8,10-pentadecadeuteriodec-9-yn-1-ol 1,1,1,3,3,3-hexaethyltrigermane 1,3,11,13-tetraaza-cycloeicosane-2,12-dithione tris(tris(dimethylsilyl)methyl)yttrium dodecacarbonyl[μ4-(η,η,η,η)(trideca-1,12-diene-5,8-diyne)]tetracobalt 4-Pentynylhydrazine (4R,5R)-2-((S)-1-Chloro-propyl)-4,5-dicyclohexyl-[1,3,2]dioxaborolane (Z)-7-Bromo-6-methyl-hept-5-en-1-yne (1S)-1-chloro-2-methylidenecyclononane;chloropalladium(1+)